SF4486

Purpose

• Expand pharmacists’ role in health care by authorizing them to initiate, prescribe, administer, and dispense certain medications, especially for opioid use disorder (OUD).
• Update requirements for pharmacist conduct and disciplinary action to reflect broader practice.
• Allow pharmacists to participate more fully in preventive care (vaccinations) and other medication-related services, within defined protocols and supervision.

Key scope and definitions

• Pharmacists can be treated as "practitioners" for more purposes, including prescribing self-administered hormonal contraception, nicotine replacement medications, opiate antagonists, and drugs to prevent HIV acquisition, under specified sections.
• The bill maintains that pharmacists work under protocols or collaborative practice agreements with other health professionals, and must document changes in the patient’s medical record.

Expanded duties and clinical activities for pharmacists

• Drug testing and interpretation: Pharmacists may collect specimens, interpret results, notify patients, and refer for follow-up care under protocol, with supervision rules for technicians/interns.
• Administration of medications and first-dose treatment: Pharmacists may initiate and administer initial doses for certain drugs and manage first dosages under protocols.
• Protocol-driven therapy changes: Pharmacists can initiate, modify, and discontinue drug therapy when guided by a written protocol or collaborative practice agreement with other licensed prescribers (e.g., dentists, optometrists, physicians, podiatrists, veterinarians, or advanced practice nurses).
• Documentation: Any changes to therapy must be recorded in the patient’s medical record or reported to the responsible practitioner.
• Vaccination authority: Pharmacists may initiate, order, and administer influenza and COVID-19 vaccines (and other FDA-approved vaccines) to eligible individuals per ACIP guidance; the program includes training, MIIC (Minnesota Immunization Information Connection) use, reporting of administration, and specific supervision and training requirements for pharmacy technicians or interns administering vaccines.
• Training and supervision: Vaccine administration training must be ACPE-approved (or board-approved), with in-person supervision of technicians, CPR certification, continuing education, and verified training programs.

Treatment of opioid use disorder (OUD)

• New authority: Pharmacists may prescribe, administer, and dispense legend drugs and controlled substances in Schedules III–V to treat OUD, if:
  • There is a medically indicated treatment plan, and
  • The pharmacist documents the assessment, treatment, response, and monitoring in the patient’s health record.
• Training and credentials: Pharmacists must complete a training program specifically developed for substance use disorder treatment (per federal standards, 21 U.S.C. § 823m) and obtain the proper DEA registration for the prescribed schedules.
• Intern involvement: Pharmacist interns may prepare prescriptions, but a pharmacist authorized to prescribe must review, approve, and sign before processing/dispensing.
• Collaboration: Pharmacists can participate in treatment under existing protocols or collaborative practice agreements, similar to other drug-therapy management activities.
• Counseling and documentation: The pharmacist must provide counseling on proper drug use, follow-up, and other information required by rules; documentation must be in the patient’s health record.
• Fees: Pharmacists may charge for these services.

Controlled substances and prescription rules

• Schedule III–IV prescriptions: The bill tightens prescription requirements for Schedule III–IV drugs, including limits on refills and timeframes (with some carve-outs for cannabis products under state law).
• Pharmacist authority to prescribe/administer: The bill adds a subdivision allowing pharmacists to prescribe, administer, and dispense Schedule III–V controlled substances under the expanded authority described above, including allowance for interns to participate under supervision.

Disciplinary actions and professional conduct

• Expanded grounds for discipline: The bill broadens and clarifies grounds for disciplinary action for pharmacists, interns, and related licensees, including:
  • Fraud in licensing or license maintenance, criminal convictions related to practice, misconduct, violations of board orders, failure to report or cooperate with investigations, and unethical or incompetent practice.
  • Conduct that endangers public health or patient safety, impairment from illness or substances, and improper management of patient records.
  • Aiding or abetting unlicensed practice, or involvement in deceptive billing or referral schemes.
  • Failures related to licensing status (lapsed/nonrenewed licenses) or disciplinary actions in other states.
• Potential consequences: The board may delay or withhold licenses or registrations pending adjudication or resolution of other disciplinary proceedings.

Implementation considerations and public health context

• Training and quality assurance: The expanded authority relies on approved training programs (ACPE or board-approved), ongoing continuing education, and documentation in patient records to ensure safe practice.
• Coordination with other health professionals: Because many duties occur under protocols or collaborative practice agreements, pharmacists will need effective collaboration with physicians, dentists, optometrists, PAs, NPs, veterinarians, and others.
• Privacy and patient records: All therapy changes and treatments must be documented in the patient’s medical record to ensure continuity of care.
• Immunization data sharing: Use of MIIC and reporting requirements will help track vaccination status and improve public health reporting.

Relevant terms - opioid use disorder (OUD) - Schedule III–V controlled substances - prescribe, administer, dispense - legend drugs - protocols and collaborative practice agreements - vaccines (influenza, COVID-19/SARS-CoV-2, ACIP recommendations) - Minnesota Immunization Information Connection (MIIC) - ACPE (Accreditation Council for Pharmacy Education) - DEA registration (Drug Enforcement Administration) - self-administered hormonal contraceptives - nicotine replacement medications - opiate antagonists - HIV prevention drug therapy - clinical protocol-based care - pharmacist intern, pharmacy technician - patient counseling and medical record documentation - disciplinary grounds and board actions - lapsed/nonrenewed license provisions